Participation in International Liver Cancer Course (ILCC) 2024
ILCC 2024 was the third National conference of STII organised by ILBS. It was held on September 28th and 29th, 2024, at The Grand New Delhi. At this conference, top International and national Hepatologists, leading researchers, and Industry experts came together to discuss managing Liver Cancer beyond Guidelines.
As we are aware, the Liver is a vital organ of the body, and in India, every 5th Indian is affected with Liver Disease. Moreover, Liver cancer is the tenth most common cancer in India. This conference highlighted newer avenues for effectively managing and treating Liver Diseases and Liver Cancer.
We, Hetero Healthcare’s Gastrocare team, participated enthusiastically in contributing to the management of Liver Disease with our innovative Hepatology Product range and our dedicated patient support initiatives.
You Might Also Like
Empowering Conversations: Hetero Gastrocare's Experience at the IBD Conference
Hetero Healthcare Gastrocare Division participated in 8th National Meeting of Colitis & Crohn’s Foundation (India), 2nd Round Table Meeting of BRICS IBD Consortium at Vizag from 4th - 6th October 2024.
DIAQUIL Launch: A New Breakthrough in Diabetic Foot Care by the DIASPA team at Hetero Healthcare
DIAQUIL Launch: A New Breakthrough in Diabetic Foot Care by the DIASPA team at Hetero Healthcare
Leadership Refined - Gastrocare MDP 2024 in Mumbai!
Our Gastrocare Team of Hetero Healthcare held a Managers Development Program (MDP) in Mumbai from 12th to 14th September 2024 to enhance the Skills and Knowledge of Managers needed to lead effectively and drive organisational success.
National Childhood Cancer Awareness Campaign "Golden Cape Hero" by Hetero Healthcare’s Oncology Division
In September, an impactful nationwide campaign titled "Golden Cape Hero" was executed by Hetero Healthcare’s Oncology Division across 33 hospitals in India to raise awareness about childhood cancer.
Hetero Healthcare Unveils DIAQUIL
We are thrilled to announce the launch of DIAQUIL, a pioneering product specifically formulated to treat Non-Healing Diabetic Foot Ulcers (NHDFU).
We Celebrate Excellence at HHCL
Big shoutout to our amazing performers of FY 2022-23! Management has recognized their hard work and dedication by awarding them two-wheelers. Congratulations to all the winners.
Honouring World Environment Day at HHCL
On June 5th, our team came together with our core customers to celebrate World Environment Day. We marked the occasion by presenting plants to our clients, reinforcing our commitment to a greener planet.
A New Launch, Like a Fresh Start!
We recently launched our prestigious TNKPLASE (Tenecteplase 40mg Injection). The team showed their enthusiasm by wearing TNKPLASE t-shirts, making the event even more special.
Volga Division Celebrates Doctors Day with a Touch of Rosebuds
This Doctors' Day, the Volga Division of Hetero Healthcare Limited took an innovative approach to show their appreciation for the medical community.
Raising the Bar: Another Triumph Unveiled Marks a New Milestone!
Exciting news! Volga Division proudly unveils 'HETROSE', a breakthrough brand combating iron deficiency anaemia.
Would you like to share your thoughts?
Your email address & phone will not be published. Required fields are marked *